Suppression of ventricular ectopy with intravenous metoprolol in patients with chronic obstructive pulmonary disease

Paul E Fenster, Stuart F Quan, C. D. Hanson, L. A. Coaker

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Intravenous metoprolol, 0.2 mg/kg, was given to 11 patients with stable, partially reversible chronic obstructive pulmonary disease (COPD) and frequent ventricular ectopic depolarizations (VEDs). The frequency of VEDs during 8 h of continuous ECG recording was reduced from a mean of 214/h to 86/h (p < .001). Four/11 patients had a greater than 90% reduction in VEDs. There were no adverse clinical effects during the period of drug administration. However, metoprolol produced small declines of 14% in the forced expiratory volume in 1 sec (FEB1) and 21% in the forced expiratory flow rate between 25% and 75% of the forced vital capacity (FVC) (FEF25-75). These data suggest that iv metoprolol is effective in reducing the frequency of VEDs in patients with COPD, although the extent of reduction in VEDs shows considerable interindividual variation. Metoprolol can be administered iv without inducing clinical bronchospasm in most patients.

Original languageEnglish (US)
Pages (from-to)29-32
Number of pages4
JournalCritical Care Medicine
Volume12
Issue number1
StatePublished - 1984

Fingerprint

Metoprolol
Chronic Obstructive Pulmonary Disease
Forced Expiratory Flow Rates
Bronchial Spasm
Vital Capacity
Forced Expiratory Volume
Electrocardiography
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Suppression of ventricular ectopy with intravenous metoprolol in patients with chronic obstructive pulmonary disease. / Fenster, Paul E; Quan, Stuart F; Hanson, C. D.; Coaker, L. A.

In: Critical Care Medicine, Vol. 12, No. 1, 1984, p. 29-32.

Research output: Contribution to journalArticle

@article{e395f0d7f9e64cf5bd058aa69ce69a15,
title = "Suppression of ventricular ectopy with intravenous metoprolol in patients with chronic obstructive pulmonary disease",
abstract = "Intravenous metoprolol, 0.2 mg/kg, was given to 11 patients with stable, partially reversible chronic obstructive pulmonary disease (COPD) and frequent ventricular ectopic depolarizations (VEDs). The frequency of VEDs during 8 h of continuous ECG recording was reduced from a mean of 214/h to 86/h (p < .001). Four/11 patients had a greater than 90{\%} reduction in VEDs. There were no adverse clinical effects during the period of drug administration. However, metoprolol produced small declines of 14{\%} in the forced expiratory volume in 1 sec (FEB1) and 21{\%} in the forced expiratory flow rate between 25{\%} and 75{\%} of the forced vital capacity (FVC) (FEF25-75). These data suggest that iv metoprolol is effective in reducing the frequency of VEDs in patients with COPD, although the extent of reduction in VEDs shows considerable interindividual variation. Metoprolol can be administered iv without inducing clinical bronchospasm in most patients.",
author = "Fenster, {Paul E} and Quan, {Stuart F} and Hanson, {C. D.} and Coaker, {L. A.}",
year = "1984",
language = "English (US)",
volume = "12",
pages = "29--32",
journal = "Critical Care Medicine",
issn = "0090-3493",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Suppression of ventricular ectopy with intravenous metoprolol in patients with chronic obstructive pulmonary disease

AU - Fenster, Paul E

AU - Quan, Stuart F

AU - Hanson, C. D.

AU - Coaker, L. A.

PY - 1984

Y1 - 1984

N2 - Intravenous metoprolol, 0.2 mg/kg, was given to 11 patients with stable, partially reversible chronic obstructive pulmonary disease (COPD) and frequent ventricular ectopic depolarizations (VEDs). The frequency of VEDs during 8 h of continuous ECG recording was reduced from a mean of 214/h to 86/h (p < .001). Four/11 patients had a greater than 90% reduction in VEDs. There were no adverse clinical effects during the period of drug administration. However, metoprolol produced small declines of 14% in the forced expiratory volume in 1 sec (FEB1) and 21% in the forced expiratory flow rate between 25% and 75% of the forced vital capacity (FVC) (FEF25-75). These data suggest that iv metoprolol is effective in reducing the frequency of VEDs in patients with COPD, although the extent of reduction in VEDs shows considerable interindividual variation. Metoprolol can be administered iv without inducing clinical bronchospasm in most patients.

AB - Intravenous metoprolol, 0.2 mg/kg, was given to 11 patients with stable, partially reversible chronic obstructive pulmonary disease (COPD) and frequent ventricular ectopic depolarizations (VEDs). The frequency of VEDs during 8 h of continuous ECG recording was reduced from a mean of 214/h to 86/h (p < .001). Four/11 patients had a greater than 90% reduction in VEDs. There were no adverse clinical effects during the period of drug administration. However, metoprolol produced small declines of 14% in the forced expiratory volume in 1 sec (FEB1) and 21% in the forced expiratory flow rate between 25% and 75% of the forced vital capacity (FVC) (FEF25-75). These data suggest that iv metoprolol is effective in reducing the frequency of VEDs in patients with COPD, although the extent of reduction in VEDs shows considerable interindividual variation. Metoprolol can be administered iv without inducing clinical bronchospasm in most patients.

UR - http://www.scopus.com/inward/record.url?scp=0021338910&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021338910&partnerID=8YFLogxK

M3 - Article

C2 - 6690202

AN - SCOPUS:0021338910

VL - 12

SP - 29

EP - 32

JO - Critical Care Medicine

JF - Critical Care Medicine

SN - 0090-3493

IS - 1

ER -